The Gary Null Show

The Gary Null Show

By Progressive Radio NetworkAlternative HealthHealth & Fitness
Download on the App Store
  • Ranking

    41st

    on Alternative Health

  • Favorites

    351

    Followers

  • Latest release

    1 day ago

  • Typical duration

    62 min

    per episode

  • If it hooks

    53%

    finish an episode

Based on Podcast App listening data

All The Gary Null Show episodes

  • The Gary Null Show - 11.07.22
    Videos:
    Michael Moore ‘Optimistic’ About Democratic Midterm Chances Because He Doesn’t ‘Live in a Bubble’ and Millions of Americans Aren’t ‘Very Bright’ (3:05)
    Dem Party Turns On Anti-War Democratic Primary Winner (2:16 to 5:28)
    Society is going to COLLAPSE -Neil Oliver ( 5:24)
    Fear Psychosis and the Cult of Safety – Why are People so Afraid?  – Academy of Ideas (13:25)
    Study reveals the powerful pain-relieving properties of ashwagandha
    Nizam Institute of Medical Science (India), October 30, 2022
    People experiencing knee joint pain and discomfort, particularly those with knee osteoarthritis, may find relief in an Ayurvedic medicine called ashwagandha(Withania somnifera). A study published in the Journal of Ayurveda and Integrative Medicine found that the root and leaf extracts of ashwagandha relieve knee pain and discomfort caused by osteoarthritis.
    In the search for safe and effective natural pain relief treatments, researchers from Nizam’s Institute of Medical Sciences (NIMS)  evaluated the efficacy and safety of the root and leaf extracts of ashwagandha in patients with knee joint pain and discomfort. Ashwagandha is known to contain analgesic, anti-inflammatory, and chondroprotective properties.
    In the study, the researchers recruited 60 patients with knee joint pain and discomfort. These participants received placebo capsules, 125 milligrams (mg) of ashwagandha extract, or 250 mg of ashwagandha extract twice a day for 12 weeks.
    The results revealed that participants who received doses of ashwagandha extracts experienced great reductions in pain, stiffness, and disability. Those who received the higher dose of ashwagandha, which was 250 mg, experienced even greater and faster effects than those who received the 125 mg dose. In addition, the ashwagandha treatment did not cause any side effect. Overall, both doses of ashwagandha extract caused significant reductions in pain, stiffness, and disability of patients in a dose-dependent manner without causing any side effect.Ashwagandha Root Supports Thyroid Hormone Levels
    Sudbhawana Hospital (India), October 31, 2022
    Eight weeks of supplementation with Ashwagandha root extract were associated with normalization of the thyroid stimulating hormones (TSH), serum thyroxine (T4) and serum triiodothyronine (T3) in people with elevated TSH levels.
    “The results of the present study are in accordance with previous studies,” wrote the researchers in the Journal of Alternative and Complementary Medicine. “The results indicate a possible role for ashwagandha in regulating HPT axis. The anti-stress and cortisol-lowering effect of ashwagandha may provide a suitable explanation for the current outcome.”
    Ashwagandha has been used traditionally as an adaptogen to rejuvenate health, maintain homeostasis, sustain normal thyroid function and maintain hormonal balance in human body. However, very few modern published papers have reported ashwagandha’s beneficial effects on thyroid function. This is the first clinical study that supports the traditional claim of ashwagandha as a thyroid modulator.
    The new double blind, randomized, placebo-controlled study involved 50 people with elevated TSH levels. So called subclinical hypothyroidism is described as a thyroid disorder with no obvious symptoms of thyroid deficiency. Participants were randomly assigned to receive either ashwagandha supplements (600mg daily) or placebo for eight weeks.
    Results showed that ashwagandha significantly improved serum TSH, serum T4 and serum T3 levels, achieving change toward normalization of 19%, 45% and 21% respectively.
    “The outcome of the present study highlights the beneficial role of ashwagandha root extract for normalizing thyroid hormone levels in subclinical hypothyroid patients; however, further studies are required to elucidate the underlying mechanisms of ashwagandha,” concluded the researchers.
    Enzyme in Broccoli, Cucumbers and Avocados Reverses Aging In Cells
    Washington University School of Medicine
    58 min
  • The Gary Null Show - 11.04.22
    VIDEOS:
    EXCLUSIVE: UNDERTAKER EXPLAINS “MYSTERIOUS” CLOTTING PHENOMENON! | Louder with Crowder (part 2)
    Society is going to COLLAPSE -Neil Oliver ( 5:24)
    Fear Psychosis and the Cult of Safety – Why are People so Afraid?  – Academy of Ideas (13:25)
     
    Dietary supplement found to improve concentration levelsUniversity of Granada, November 3, 2022
    The research group from the University of Granada (UGR) has tested the effects of a multi-ingredient dietary nootropic on concentration levels and cognitive performance. Nootropics are cognitive enhancers that have traditionally been used in the treatment of cognitive pathologies.
    Leading this study was Lucas Jurado Fasoli—a researcher from the Scientific Unit of Excellence in Exercise, Nutrition and Health (UCEENS) at the Sport and Health Joint University Institute (iMUDS). He explains that, traditionally, nootropics have been drugs, with their corresponding side-effects.
    “To address the issue of potential side-effects, different dietary nootropics have emerged as an alternative way to enhance cognitive performance. And these, as is the case in this study, are used by healthy individuals in activities such as preparing for competitive exams or video-game competitions,” explains Jurado Fasoli.
    The results of the study showed that the acute intake of this multi-ingredient nootropic decreases the response time across different cognitive tests: in processing speed, inhibitory control, working memory, and cognitive flexibility. It also increases accuracy in tests involving processing speed, inhibitory control, and cognitive flexibility. The supplement contains L-tyrosine, acetyl L-carnitine, sodium citicoline, alpha-GPC, taurine, caffeine, mango leaf extract and huperzia serrata leaf.
    These results were accompanied by an increase in positive emotions and a decrease in negative emotions and depression. And, importantly, the favorable effects of this nootropic did not appear to have any effect on the heart-rate of participants.
    Previous studies have shown that supplementation with the combination of caffeine and taurine, L-theanine, tyrosine, and mango leaves extract can improve the RT in different cognitive and computerized tests. In this study, we showed that a dietary multi-ingredient nootropic improves the processing speed of information in young healthy adults. This effect could be due to the synergic effects of different dietary ingredients included in the nootropic. Also, it could be partially explained by the central nervous system activation and alertness enhancement effect of caffeine, which could increase the processing speed and decrease the RT. The inclusion of L-theanine as a dietary ingredient in the nootropic counteracts the potential effects derived from a high dose of caffeine on anxiety, psychological stress, blood pressure, and HR, which completely agrees with our results.
    A sample comprising 26 young adults (50:50 male/female, with an average age of 25) participated in the study. They were required to undertake various cognitive tests twice, separated by 48 hours, having ingested either the multi-ingredient dietary nootropic or a placebo (randomized and triple-blinded across the sample).
    Thirty minutes after ingestion, measurements were taken of processing speed, inhibitory control, working memory, cognitive flexibility, creativity, and verbal fluency. Different emotions were also evaluated and the participants’ heart-rate was recorded while they undertook the tests.
    Consuming more magnesium associated with lower risk of mortality during years following heart attackWageningen University and Research (Netherlands), October 31, 2022
    A study of people with a history of heart attack found that those who consumed more magnesium lived longer than those whose intake was low. Having a high magnesium intake, defined as greater than 320 milligrams (mg) per day, was associated with a 28% lower risk of dying from cardiovascular disease and a 22% lower risk of death from an
    1 hr 3 min
  • The Gary Null Show - 11.03.22
    Videos:
    Did Julian Assange’s lawyers just EXPOSE this CIA scheme? Redacted with Natali and Clayton Morris (3:23 to 6:46)
    EXCLUSIVE: UNDERTAKER EXPLAINS “MYSTERIOUS” CLOTTING PHENOMENON! | Louder with Crowder (8:17 – 26:00)
     
    Green tea and resveratrol reduce Alzheimer’s plaques in lab testsTufts University, November 2, 2022
    Tufts researchers are working to understand what might slow progression of Alzheimer’s disease. They have tested 21 different compounds in Alzheimer’s-afflicted neural cells in the lab, measuring the compounds’ effect on the growth of sticky beta amyloid plaques. These plaques develop in the brains of people with Alzheimer’s.
    The researchers found that two common compounds—green tea catechins and resveratrol, found in red wine and other foods—reduced the formation of plaques in those neural cells. And they did so with few or no side effects. The researchers reported their findings in the journal Free Radical Biology and Medicine.
    Some of the 21 compounds tested reduced the disease progression by acting as anti-viral agents—slowing Alzheimer’s induced by the herpes virus. But finding a compound “that could diminish the plaques regardless of the virus component would be ideal, because that would show that regardless of the cause of Alzheimer’s, you might still see some kind of improvement,” says Dana Cairns, GBS12. Cairns is a research associate in the Kaplan Lab in the School of Engineering and led the research.
    The initial screen found five compounds had “really robust prevention of these plaques,” she says. In addition to the green tea compounds and resveratrol, they found curcumin from turmeric, the diabetic medication Metformin, and a compound called citicoline prevented plaques from forming and did not have anti-viral effects.
    “We hoped to find compounds that would be harmless and show some level of efficacy,” she said. Green tea compounds and resveratrol met that standard. “We got lucky that some of these showed some pretty strong efficacy,” Cairns said. “In the case of these compounds that passed the screening, they had virtually no plaques visible after about a week.”
    The discovery is significant because there is no cure for Alzheimer’s or a way to prevent its progression, aside from several potential drugs developed by pharmaceutical companies that are still in trials, Cairns says. Compounds like these two that show some efficacy and are known to be safe and easily accessible could be taken as a supplement or consumed as part of one’s diet, she adds.
    High fiber, yogurt diet associated with lower lung cancer riskVanderbilt University Medical School, October 28, 2022
    A diet high in fiber and yogurt is associated with a reduced risk for lung cancer, according to a study by Vanderbilt University Medical Center researchers published in JAMA Oncology.
    The benefits of a diet high in fiber and yogurt have already been established for cardiovascular disease and gastrointestinal cancer. The new findings based on an analysis of data from studies involving 1.4 million adults in the United States, Europe and Asia suggest this diet may also protect against lung cancer.
    Participants were divided into five groups, according to the amount of fiber and yogurt they consumed. Those with the highest yogurt and fiber consumption had a 33% reduced lung cancer risk as compared to the group who did not consume yogurt and consumed the least amount of fiber.
    “This inverse association was robust, consistently seen across current, past and never smokers, as well as men, women and individuals with different backgrounds,” she added. Shu said the health benefits may be rooted in their prebiotic (nondigestible food that promotes growth of beneficial microorganisms in the intestines) and probiotic properties. The properties may independently or synergistically modulate gut microbiota in a beneficial way.
    Yoga Practice Beneficial to Patients With COPD
    All India Institute of Medical Sciences Oct. 28, 2022
    Patients with COPD
    1 hr 4 min
  • The Gary Null Show - 11.02.22
    VIDEOS:
    Mark Dolan: Covid has been the biggest “I told you so” in history (4:41)
    Society is going to COLLAPSE (5:24)
    Fear Psychosis and the Cult of Safety – Why are People so Afraid? (13:25)
    MSNBC Midterm PANIC꞉ ‘It’s Going To Be a BLOODBATH’!!! (0:18 – 3:32)
    Pycnogenol, gotu kola supplementation associated with decreased progression of atherosclerosisD’Annunzio University (Italy), October 23, 2022
    The results of studies published in Minerva Cardioangiologica suggest a benefit for supplementation with extracts of pine bark and the herb gotu kola in atherosclerosis.
    In one study, participants with arterial wall atherosclerotic lesions and intima-media thickening (thickening of the artery walls’ innermost layers) received standard management, standard management plus aspirin, or standard management, aspirin and Pycnogenol® pine bark extract plus gotu kola extract daily for three years, after which atherosclerotic lesion progression, carotid artery intima-media thickness and oxidative stress were assessed.
    At the end of the trial, 5.3% of those who received Pycnogenol and gotu kola had experienced atherosclerotic lesion progression in comparison with over 20% of the remainder of the participants. Cardiovascular events that required hospital admission were less than 4% in the supplemented group compared to over 12% in the rest of the subjects. Carotid artery intima thickness and oxidative stress were also lower in association with supplementation.
    In the second study, 90 men with coronary artery calcifications received standard management alone, standard management and daily Pycnogenol, or standard management with daily Pycnogenol plus gotu kola. All participants received daily aspirin. Calcification was assessed at the beginning of the study and after one year.
    While Pycnogenol plus standard management was more effective than standard management alone, men who received Pycnogenol plus gotu kola experienced a 10% decline in the number of calcifications by the end of the study, in contrast with a 34.9% increase in the standard management group. “This indicates that supplementation with the combined supplements blocks the increase in calcified areas and, possibly, in time may decrease the number of calcified spots,” Shu Hu and colleagues write.
    Effects of pistachios on cardiovascular disease risk factors and potential mechanisms of action: a dose-response study.Pennsylvania State University, October 22, 2022Nut consumption lowers cardiovascular disease (CVD) risk. Studies are lacking about the effects of pistachios, a nutrient-dense nut, on CVD risk factors, dose-response relations, and lipid-lowering mechanisms.
    We evaluated the effects of 2 doses of pistachios, added to a lower-fat diet, on lipids and lipoproteins, apolipoprotein (apo)-defined lipoprotein subclasses, and plasma fatty acids. To investigate the mechanisms of action, we measured cholesteryl ester transfer protein and indexes of plasma stearoyl-CoA desaturase activity (SCD).
    In a randomized crossover controlled-feeding study, 28 individuals with LDL cholesterol > or = 2.86 mmol/L consumed 3 isoenergetic diets for 4 wk each. Baseline measures were assessed after 2 wk of a typical Western diet. The experimental diets included a lower-fat control diet with no pistachios [25% total fat; 8% saturated fatty acids (SFAs), 9% monounsaturated fatty acids (MUFAs), and 5% polyunsaturated fatty acids (PUFAs)], 1 serving/d of a pistachio diet (1 PD; 10% of energy from pistachios; 30% total fat; 8% SFAs, 12% MUFAs, and 6% PUFAs), and 2 servings/d of a pistachio diet (2 PD; 20% of energy from pistachios; 34% total fat; 8% SFAs, 15% MUFAs, and 8% PUFAs).
    Inclusion of pistachios in a healthy diet beneficially affects CVD risk factors in a dose-dependent manner, which may reflect effects on SCD.
    Poor quality sleep may be linked to heightened risk of glaucoma, irreversible sight lossSichuan University (China), November 1, 2022
    Poor quality sleep, including too much or too li
    1 hr 2 min
  • The Gary Null Show - Interview With Michael Hudson
    Dr. Michael Hudson is one of our nation’s finest and most important economists and Wall Street financial analysts. Dr. Paul Craig Roberts has called Michael “the world’s best economist.” He is the President of The Institution for the Study of Long-Term Economic Trends, and a distinguished research professor of economics at the University of Missouri. He was the Chief Economic Policy Advisor for the Rep. Dennis Kucinich’s 2008 presidential campaign and has served as an adviser to the White House, State and Defense departments and served as an economic advisor to other governments including Iceland, Latvia and China.  Michael has written many books and important papers and articles. His most recent must-read book is "The Destiny of Civilization: Finance Capitalism, Industrial Capitalism or Socialism" which explains the reason for crisis in the US and other Western nations due to a drainage o income, indebtedness and a collapse of industrialization. His website is Michael-Hudson.com
    37 min
  • The Gary Null Show - 11.01.22
    Videos:
    Dad STUNS School Board When He Reads Aloud DISGUSTING Book From Library (3:37)
    RFK : The Real Anthony Fauci Clip (1st clip 5:50 – 2nd Clip 4:37)
    Dr. Michael Hudson Interview 
    Neil Oliver: We are expected to forget those promising to fix the disaster caused it (10:28)
    Almonds can help support the gut microbiome, study claimsKings College London, October 31, 2022A new study finds that eating 56 grams of almonds daily — the equivalent of approximately 46 almonds — can improve gut health by promoting levels of butyrate.The research involved three groups replacing their regular snacks with whole almonds, ground almonds, or an energy-equivalent control muffin.The authors conclude that incorporating almonds into the diet could be a way of increasing fiber intake without triggering gut symptoms.An important player in gut health appears to be butyrate, a short-chain fatty acid that supports the health of the microbiome itself.
    Dr. Alice Creedon explained to Medical News Today: “Butyrate is important to gut health, as it acts as the primary source of fuel for the cells of the colon, allowing them to function correctly and optimally. It is also involved in signaling to the gut to initiate the process of nutrient absorption.”
    “In addition,” said Dr. Creedon, “butyrate produced in the gut can enter the bloodstream where it is involved in the regulation of health in other areas of the body, such as the liver, brain, and lungs.”
    The study demonstrates that eating a healthy handful of almonds each day promotes the production of butyrate.
    Dr. Creedon’s research documents the benefits of eating about 56 grams, or 2 ounces, of almonds daily — that amounts to about 46 almonds.
    “Butyrate supports the gut barrier, which keeps bacteria and other microbes from entering your blood. In doing so, butyrate can help to reduce inflammation, manage conditions like IBS [irritable bowel syndrome], and decrease gastrointestinal discomfort like bloating.
    “Butyrate is produced through the fermentation of fiber in the colon. Therefore, increasing fiber in the diet, such as in almonds, increases butyrate levels, which has a positive effect on our gut health,” said Tallman.
    Additional benefit of omega-3 fatty acids for the clearance of metabolites from the brain
    Federation of American Societies for Experimental Biology, October 23, 2022
    New research published online in The FASEB Journal suggests that omega-3 polyunsaturated fatty acids, which are found in fish oil, could improve the function of the glymphatic system, which facilitates the clearance of waste from the brain, and promote the clearance of metabolites including amyloid-β peptides, a primary culprit in Alzheimer’s disease.
    To make this discovery, scientists first used transgenic fat-1 mice, which express high endogenous omega-3 polyunsaturated fatty acids (PUFAs) in the brain, to investigate the effect of omega-3 PUFAs on the clearance function of the glymphatic system. Compared to the wild-type mice, the fat-1 mice with enriched endogenous omega-3 PUFAs significantly promote the clearance function of the lymphatic system, including the Aβ clearance from the brain. Wild-type mice were supplemented with fish oil, which contains high concentrations of omega-3 PUFAs, and found that fish oil-supplemented mice also improved the clearance function of the glymphatic system compared to the control mice without fish oil supplementation. Omega-3 PUFAs help maintain the brain homeostasis, which may provide benefits in a number of neurological diseases, such as Alzheimer’s disease, traumatic brain injury, and sleep impairment, among others.
    “These now-famous fatty acids have been the subject of major studies both in academia and industry. Just when we thought we had heard everything, here is something new, and it is provocative indeed,” said Thoru Pederson, Ph.D., Editor-in-Chief of The FASEB Journal. “This study should not turn attention away from the roles of these substances in maintaining vas
    1 hr 1 min
  • The Gary Null Show - 10.31.22
    Videos:
    Member of The FDA Vax Panel Said “We Are Killing More People Than We Are Saving With The Shots”
    RFK : The Real Anthony Fauci Clip (1st clip 5:50 – 2nd Clip 4:37)
    Dr Shoemaker – C19 vaxx – lethal short and long term 10/22/22 (13:00)
    Clare Daly Latest Top 7 Contributions in the EU. (Start @ 4:32)
    Neil Oliver: We are expected to forget those promising to fix the disaster caused it (10:28)
    MASSIVE GLACIER MELTDOWN THREATENS CIVILIZATION | Countdown to Armageddon (7:42)
    Chlorophyllin shows promise for inflammatory bowel disease
    Sichuan University (China) & Cedars Sinai Medical Center, October 28 2022. 
    The August 2022 issue of the American Journal of Physiology Gastrointestinal and Liver Physiology reported research which found that supplementation with chlorophyllin suppressed intestinal inflammation in a mouse model of inflammatory bowel disease (IBD). 
    Chlorophyllin is a water-soluble derivative of chlorophyll, the pigment that gives green plants their color. “Consuming green-colored vegetables or green pigment supplement such as chlorophyllin might help people with inflammatory bowel disease,” senior author Xiaofeng Zheng, PhD, of Sichuan University West China Hospital in Chengdu, China predicted. 
    Current treatments for inflammatory bowel diseases include immunosuppressant medications and surgery, both of which are associated with potentially serious adverse effects. “The study was designed to determine the effect of safe agents that are easily available to have a beneficial effect in inflammatory bowel disease,” commented report coauthor Stephen J. Pandol, MD, of Cedars Sinai Medical Center in Los Angeles.
    The team induced colitis in mice by administering dextran sulfate sodium. They found that supplementing the animals’ diets with chlorophyllin or directly administering the compound suppressed intestinal inflammation and downregulated disease-associated autophagy in the intestine. 
    “What we found in the study was that the agent used, chlorophyllin, would inhibit the inflammation and tissue damage that occurs in an experimental model of colitis,” Dr Pandol commented. “In this case it was in a mouse model. The results were promising in an experimental model, and those can justify a clinical trial.”
    Curcumin Prodrug Shows Promise As Cancer Treatment Without Toxic Side Effects
    Kyoto University (Japan), October 30, 2022
    Curcumin, the biologically active compound found in turmeric, has shown lots of promise in clinical cancer research. A new study from Kyoto University adds more evidence that supports its use in clinical-care settings. Researchers are developing a curcumin prodrug called TBP1901 that demonstrates anti-tumor effects without adverse toxicities.
    Curcumin is an appealing compound for oncology researchers, as many current pharmacological treatments lead to significant side effects in patients. Thus far, anecdotal findings report strong efficacy when taken orally among cancer patients. However, until this recent development, curcumin’s low bioavailability and instability has put limitations on its clinical use.
    Kanai and team have maneuvered their way around this by successfully identifying the enzyme GUSB, which may activate curcumin to increase its bioavailability. The enzyme plays a crucial role in TBP1901 conversion to curcumin. However, the research team hypothesized that the conversion wouldn’t be observable in mice with genetically-weakened GUSB enzyme.
    Further, they were able to confirm through analysis with CRISPR-Cas9 screening that curcumin may also have additional specific therapeutic targets. “The high conversion rate of TBP1901 to curcumin in bone marrow warrants its clinical application for diseases growing in the marrow like multiple myeloma and leukemia,” states Kanai.
    Now that scientists have begun to crack the code with curcumin, the cancer field may start to put things into motion as more targets and enzymatic processes are explained. 
    Study Reveals How Turmeric Inhibits Pancreati
    1 hr 4 min
  • The Gary Null Show - 10.28.22
    Researchers find Cordyceps used in traditional medicine can fight cancerShanghai Institutes for Biological Sciences, October 23, 2022
    Chinese scientists have found evidence that a fungus used in traditional Chinese medicine widely sought by the public for its healing powers, also carries anti-cancer benefits.
    The scientists found there was an interaction between two anti-cancer compounds in the fungus Cordyceps militaris.
    The first, cordycepin, was noted in Cordyceps militaris in 1950, but how it interacted remained unknown. The second, pentostatin, was first identified from a bacterium and was developed as a commercial drug to treat leukemia and other cancers in the 1990s.
    “For the first time, we decoded the biosynthesis mechanism of cordycepin in the fungus, and during the research we unexpectedly discovered pentostatin,” said Wang Chengshu, head of the research team at the Institute of Plant Physiology and Ecology, a branch of the Shanghai Institutes for Biological Sciences of the Chinese Academy of Sciences.
    “These two compounds coexist in fungal cells in the form of a protector and protege – that is to say, cordycepin is synthesized with the coupled production of pentostatin to protect the stability of the former,” he said.
    Their research also showed that the fungus initiates a detoxification process when the cordycepin in the body reaches an excessively high level, which can be toxic.
    Cordyceps fungi are popular in China for their widely believed immunity-enhancing and energy-strengthening properties. Their uses in medical treatment date to the Compendium of Materia Medica, a book widely deemed the encyclopedia of traditional Chinese medicine written in the Ming Dynasty (1368-1644).
    Omega-3 fatty acid could boost IQ for preterm babiesSouth Australian Health and Medical Research Institute, October 27, 2022
    New research from SAHMRI has found a link between the omega-3 fatty acid known as docosahexaenoic acid (DHA) and increased IQ among children born prematurely.
    Preterm children are more likely to have lower IQ scores and cognitive impairments compared with term-born children.
    Dr. Jacqueline Gould, who led the study now published in the New England Journal of Medicine, says infants born at the earliest gestations are deprived of the natural supply of DHA that normally builds up in the brain during the last trimester of pregnancy. “These babies have low concentrations of DHA in their brain tissue, which may contribute to poorer cognitive outcomes,” Dr. Gould said.
    The study followed 323 infants born before 29 weeks’ gestation, who were given 60mg of DHA/kg per day via enteral or control tube feeding.
    They were compared with 333 children in the control group, who received an emulsion with no DHA. At five years old, children in both groups underwent the Wechsler Preschool and Primary Scale of Intelligence (WPPSI) IQ test.
    “On average, those in the DHA group scored 3.5 points higher on the IQ scale than those in the control group,” Dr. Gould said.
    “These very promising results suggest DHA has the potential to improve cognitive performance when administered via emulsion for infants born before 29 weeks’ gestation.”
    Crossword puzzles beat computer video games in slowing memory lossColumbia University Irving Medical Center & Duke University, October 27, 2022
    A new study by researchers from Columbia University and Duke University published in the journal NEJM Evidence shows that doing crossword puzzles has an advantage over computer video games for memory functioning in older adults with mild cognitive impairment.
    In a randomized, controlled trial, led by D.P. Devanand, MD, professor of psychiatry and neurology at Columbia, with Murali Doraiswamy, MD, professor of psychiatry and medicine at Duke, researchers determined that participants (average age 71) trained in doing web-based crossword puzzles demonstrated greater cognitive improvement than those who were trained on cognitive video games.
    “This is the first study
    1 hr 3 min
  • The Gary Null Show - 10.27.22
    Videos:
    A.I. Is Making it Easier to Kill (You). Here’s How. | NYT (10:00)
    Disturbing simulation shows power, terror of killer robots (7:46)
    Fear Psychosis and the Cult of Safety – Why are People so Afraid? (13:25)
     
    Peanuts Linked to Lower Breast Cancer Risk
    Washington University in St. Louis & Harvard University, October 22, 2022
    Girls ages 9 to 15 who regularly ate peanut butter or nuts were 39 percent less likely to develop benign breast disease by age 30, according to a new study.
    Benign breast disease, although noncancerous, increases risk of breast cancer later in life.
    “These findings suggest that peanut butter could help reduce the risk of breast cancer in women,” says senior author Graham Colditz, professor of surgery at Washington University School of Medicine and associate director for cancer prevention and control at Siteman Cancer Center at Barnes-Jewish Hospital.
    Published in the journal Breast Cancer Research and Treatment, the findings are based on the health histories of 9,039 US girls enrolled in the Growing Up Today Study .
    When the study participants were 18 to 30 years old, they reported whether they had been diagnosed with benign breast disease that had been confirmed by breast biopsy.
    Participants who ate peanut butter or nuts two times each week were 39 percent less likely to have developed benign breast disease than those who never ate them.
    The study’s findings suggest that beans, lentils, soybeans, and corn also may help prevent benign breast disease, but consumption of these foods was much lower in these girls so the evidence was weaker.
    Past studies have linked peanut butter, nut, and vegetable fat consumption to a lower risk for benign breast disease. However, participants in those studies were asked to recall their high school dietary intakes years later.
    Perinatal Brain DHA Concentration Has a Lasting Impact on CognitionNational Institute on Alcohol Abuse and Alcoholism October 20, 2022
    A new study on Proteomics is now available. According to news out of Bethesda, Maryland, research stated, “Premature infants are deprived of prenatal accumulation of brain docosahexaenoic acid [DHA (22: 6n-3)], an omega-3 fatty acid [omega-3 FA (n-3 FA)] important for proper development of cognitive function. The resulting brain DHA deficit can be reversed by omega-3 FA supplementation.”
    “The objective was to test whether there is a critical period for providing omega-3 FA to correct cognitive deficits caused by developmental omega-3 FA deprivation in mice. Twelve timed-pregnant mice were fed an omega-3 FA-deficient diet containing 0.04% a-linolenic acid, and their offspring were fed the same deficient diet (Def group) or changed to an omega-3 FA-adequate diet containing 3.1% ALA at 3 wk, 2 mo, or 4 mo of age. In parallel, 3 E14 pregnant mice were fed the adequate diet and their offspring were fed the same diet (Adeq group) throughout the experiment. Brain FA composition, learning and memory, and hippocampal synaptic protein expression were evaluated at 6 mo by gas chromatography, the Morris water maze test, and western blot analysis, respectively.
    Maternal dietary omega-3 FA deprivation decreased DHA by > 50% in the brain of their offspring at 3 wk of age. The Def group showed significantly worse learning and memory at 6 mo than those groups fed the adequate diet. These pups also had decreased hippocampal expression of postsynaptic density protein 95 (43% of Adeq group), Homer protein homolog 1 (21% of Adeq group), and synaptosome-associated protein of 25 kDa (64% of Adeq group).
    Changing mice to the adequate diet at 3 wk, 2 mo, or 4 mo of age restored brain DHA to the age-matched adequate concentration. However, deficits in hippocampal synaptic protein expression and spatial learning and memory were normalized only when the diet was changed at 3 wk.”
    The research concluded: “Developmental deprivation of brain DHA by dietary omega-3 FA depletion in mice may have a lasting impact on cognitive function
    58 min
  • The Gary Null Show - 10.26.22
    Videos :
    Robby Soave: PayPal Threatens To Take $2,500 From Users Who Promote ‘Misinformation’ (9:26)
    ED DOWD: COVID AND THE GLOBAL FINANCIAL COLLAPSE: A TALE OF CATASTROPHES AND COVER-UPS (32:50 – 42:50)
    Tidal energy could be huge – why isn’t it? (4:00)
    Back To the Future of Wind Energy Technology with Paul Gipe (7:23)
    No, this angry AI isn’t fake (see comment), w Elon Musk. (3:24)
    Dr. Bhakdi Clip (7:27)
     
    Study shows inexpensive, readily available chemical (GABA) may limit impact of COVID-19
    University of California, Los Angeles, October 25, 2022
    Preclinical studies in mice that model human COVID-19 suggest that an inexpensive, readily available amino acid might limit the effects of the disease and provide a new off-the-shelf therapeutic option for infections with SARS-CoV-2 variants and perhaps future novel coronaviruses.
    A team led by researchers at the David Geffen School of Medicine at UCLA report in Frontiers in Immunology that an amino acid called GABA, which is available over-the-counter in many countries, reduced disease severity, viral load in the lungs, and death rates in SARS-CoV-2-infected mice. This follows up on their previous finding that GABA consumption also protected mice from another lethal mouse coronavirus called MHV-1. In both cases, GABA treatment was effective when given just after infection or several days later near the peak of virus production. The protective effects of GABA against two different types of coronaviruses suggest that GABA may provide a generalizable therapy to help treat diseases induced by new SARS-CoV-2 variants and novel beta-coronaviruses. 
    Their previous studies showed that GABA administration protected mice from developing severe disease after infection with a mouse coronavirus called MHV-1. To more stringently test the potential of GABA as a therapy for COVID-19, they studied transgenic mice that when infected with SARS-CoV-2 develop severe pneumonia with a high mortality rate. “If our observations of the protective effects of GABA therapy in SARS-CoV-2-infected mice are confirmed in clinical trials, GABA could provide an off-the-shelf treatment to help ameliorate infections with SARS-CoV-2 variants. GABA is inexpensive and stable at room temperature, which could make it widely and easily accessible, and especially beneficial in developing countries.”
    The researchers said that GABA and GABA receptors are most often thought of as a major neurotransmitter system in the brain. Years ago, they, as well as other researchers, found that cells of the immune system also possessed GABA receptors and that the activation of these receptors inhibited the inflammatory actions of immune cells. Taking advantage of this property, the authors reported in a series of studies that GABA administration inhibited autoimmune diseases such as type 1 diabetes, multiple sclerosis, and rheumatoid arthritis in mouse models of these ailments.
    Other scientists who study gas anesthetics have found that lung epithelial cells also possess GABA receptors and that drugs that activate these receptors could limit lung injuries and inflammation in the lung. The dual actions of GABA in inflammatory immune cells and lung epithelial cells, along with its safety for clinical use, made GABA a theoretically appealing candidate for limiting the overreactive immune responses and lung damage due to coronavirus infection.
    Working with colleagues at the University of Southern California, the UCLA research team in this study administered GABA to the mice just after infection with SARS-CoV-2, or two days later when the virus levels are near their peak in the mouse lungs. While the vast majority of untreated mice did not survive this infection, those given GABA just after infection, or two days later, had less illness severity and a lower mortality rate over the course of the study. Treated mice also displayed reduced levels of virus in their lungs and changes in circulating immune signaling molecules, known as cytok
    1 hr 3 min